These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

265 related articles for article (PubMed ID: 17434923)

  • 1. Functional characterization of single-nucleotide polymorphisms and haplotypes of human N-acetyltransferase 2.
    Zang Y; Doll MA; Zhao S; States JC; Hein DW
    Carcinogenesis; 2007 Aug; 28(8):1665-71. PubMed ID: 17434923
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of single nucleotide polymorphisms in human N-acetyltransferase 2 on metabolic activation (O-acetylation) of heterocyclic amine carcinogens.
    Hein DW; Fretland AJ; Doll MA
    Int J Cancer; 2006 Sep; 119(5):1208-11. PubMed ID: 16570281
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structure/function evaluations of single nucleotide polymorphisms in human N-acetyltransferase 2.
    Walraven JM; Zang Y; Trent JO; Hein DW
    Curr Drug Metab; 2008 Jul; 9(6):471-86. PubMed ID: 18680467
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Functional characterization of human N-acetyltransferase 2 (NAT2) single nucleotide polymorphisms.
    Fretland AJ; Leff MA; Doll MA; Hein DW
    Pharmacogenetics; 2001 Apr; 11(3):207-15. PubMed ID: 11337936
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Functional characterization of the A411T (L137F) and G364A (D122N) genetic polymorphisms in human N-acetyltransferase 2.
    Zang Y; Zhao S; Doll MA; States JC; Hein DW
    Pharmacogenet Genomics; 2007 Jan; 17(1):37-45. PubMed ID: 17264801
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metabolic activation of N-hydroxyarylamines and N-hydroxyarylamides by 16 recombinant human NAT2 allozymes: effects of 7 specific NAT2 nucleic acid substitutions.
    Hein DW; Doll MA; Rustan TD; Ferguson RJ
    Cancer Res; 1995 Aug; 55(16):3531-6. PubMed ID: 7627960
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of the rs1799931 G857A (G286E) polymorphism on N-acetyltransferase 2-mediated carcinogen metabolism and genotoxicity differs with heterocyclic amine exposure.
    Hein DW; Salazar-González RA; Doll MA; Zang Y
    Arch Toxicol; 2023 Oct; 97(10):2697-2705. PubMed ID: 37592049
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Catalytic properties and heat stabilities of novel recombinant human N-acetyltransferase 2 allozymes support existence of genetic heterogeneity within the slow acetylator phenotype.
    Hein DW; Doll MA
    Arch Toxicol; 2017 Aug; 91(8):2827-2835. PubMed ID: 28523442
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of N-acetyltransferase 2 acetylation polymorphism in 4, 4'-methylene bis (2-chloroaniline) biotransformation.
    Hein DW; Zhang X; Doll MA
    Toxicol Lett; 2018 Feb; 283():100-105. PubMed ID: 29180287
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Functional genomics of C190T single nucleotide polymorphism in human N-acetyltransferase 2.
    Zhu Y; Doll MA; Hein DW
    Biol Chem; 2002 Jun; 383(6):983-7. PubMed ID: 12222688
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acetylation of putative arylamine and alkylaniline carcinogens in immortalized human fibroblasts transfected with rapid and slow acetylator N-acetyltransferase 2 haplotypes.
    Leggett CS; Doll MA; States JC; Hein DW
    Arch Toxicol; 2021 Jan; 95(1):311-319. PubMed ID: 33136180
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The T341C (Ile114Thr) polymorphism of N-acetyltransferase 2 yields slow acetylator phenotype by enhanced protein degradation.
    Zang Y; Zhao S; Doll MA; States JC; Hein DW
    Pharmacogenetics; 2004 Nov; 14(11):717-23. PubMed ID: 15564878
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genetic heterogeneity among slow acetylator N-acetyltransferase 2 phenotypes in cryopreserved human hepatocytes.
    Doll MA; Hein DW
    Arch Toxicol; 2017 Jul; 91(7):2655-2661. PubMed ID: 28516247
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Improvements in algorithms for phenotype inference: the NAT2 example.
    Selinski S; Blaszkewicz M; Ickstadt K; Hengstler JG; Golka K
    Curr Drug Metab; 2014 Feb; 15(2):233-49. PubMed ID: 24524665
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 4-Aminobiphenyl downregulation of NAT2 acetylator genotype-dependent N- and O-acetylation of aromatic and heterocyclic amine carcinogens in primary mammary epithelial cell cultures from rapid and slow acetylator rats.
    Jefferson FA; Xiao GH; Hein DW
    Toxicol Sci; 2009 Jan; 107(1):293-7. PubMed ID: 18842621
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genotyping NAT2 with only two SNPs (rs1041983 and rs1801280) outperforms the tagging SNP rs1495741 and is equivalent to the conventional 7-SNP NAT2 genotype.
    Selinski S; Blaszkewicz M; Lehmann ML; Ovsiannikov D; Moormann O; Guballa C; Kress A; Truss MC; Gerullis H; Otto T; Barski D; Niegisch G; Albers P; Frees S; Brenner W; Thüroff JW; Angeli-Greaves M; Seidel T; Roth G; Dietrich H; Ebbinghaus R; Prager HM; Bolt HM; Falkenstein M; Zimmermann A; Klein T; Reckwitz T; Roemer HC; Löhlein D; Weistenhöfer W; Schöps W; Hassan Rizvi SA; Aslam M; Bánfi G; Romics I; Steffens M; Ekici AB; Winterpacht A; Ickstadt K; Schwender H; Hengstler JG; Golka K
    Pharmacogenet Genomics; 2011 Oct; 21(10):673-8. PubMed ID: 21750470
    [TBL] [Abstract][Full Text] [Related]  

  • 17. NAT2 polymorphisms associated with the development of hepatotoxicity after first-line tuberculosis treatment in Mexican patients: From genotype to molecular structure characterization.
    Herrera-Rodulfo A; Carrillo-Tripp M; Laura Yeverino-Gutierrez M; Peñuelas-Urquides K; Adiene González-Escalante L; Bermúdez de León M; Silva-Ramirez B
    Clin Chim Acta; 2021 Aug; 519():153-162. PubMed ID: 33932406
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of single nucleotide polymorphisms on human N-acetyltransferase 2 structure and dynamics by molecular dynamics simulation.
    Rajasekaran M; Abirami S; Chen C
    PLoS One; 2011; 6(9):e25801. PubMed ID: 21980537
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Monomorphic and polymorphic human arylamine N-acetyltransferases: a comparison of liver isozymes and expressed products of two cloned genes.
    Grant DM; Blum M; Beer M; Meyer UA
    Mol Pharmacol; 1991 Feb; 39(2):184-91. PubMed ID: 1996083
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Codominant expression of N-acetylation and O-acetylation activities catalyzed by N-acetyltransferase 2 in human hepatocytes.
    Doll MA; Zang Y; Moeller T; Hein DW
    J Pharmacol Exp Ther; 2010 Aug; 334(2):540-4. PubMed ID: 20430842
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.